Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)
Top Cited Papers
Open Access
- 1 November 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (9) , 2942-2949
- https://doi.org/10.1182/blood-2006-05-021782
Abstract
We have investigated the in vivo safety, efficacy, and persistence of autologous Epstein Barr virus (EBV)–specific cytotoxic T lymphocytes (CTLs) forKeywords
This publication has 34 references indexed in Scilit:
- Treatment of EBV-Related Post-Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV-Specific T CellsAmerican Journal of Transplantation, 2005
- Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytesBlood, 2005
- Post-Transplant Lymphoproliferative DisordersAnnual Review of Medicine, 2005
- Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapyTransplantation, 2003
- Autologous Epstein-Barr virus (EBV)–specific cytotoxic T cells for the treatment of persistent active EBV infectionBlood, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cellsThe Lancet, 2002
- Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesAnnual Review of Microbiology, 2000
- SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1Transplantation, 1998
- Feasibility of Cellular Adoptive Immunotherapy for Epstein-Barr Virus-Associated Lymphomas Using Haploidentical DonorsJournal of Hematotherapy, 1998